Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:CQP
NYSE:CQPOil and Gas

Does Cheniere Energy Partners' Base‑Plus‑Variable Payout Reveal a New Capital Strategy for CQP?

Cheniere Energy Partners, L.P. recently declared a quarterly cash distribution of US$0.830 per common unit, comprising a US$0.775 base and a US$0.055 variable component, payable on February 13, 2026, to unitholders of record as of February 9, 2026. The blend of a recurring base payout with a smaller variable element highlights how the partnership balances ongoing income needs with flexibility around its liquefied natural gas export operations and tax considerations for foreign investors. We...
BME:ALM
BME:ALMPharmaceuticals

Is China’s Seysara Approval and Sinomune Deal Altering The Investment Case For Almirall (BME:ALM)?

Almirall has reported that China’s National Medical Products Administration approved Seysara (sarecycline hydrochloride) for treating inflammatory lesions of non-nodular moderate-to-severe acne in patients aged 9 and older, with Sinomune holding exclusive commercialization and distribution rights in China. This marks the first approval in China of a tetracycline-derived oral antibiotic developed specifically for dermatology, expanding Seysara’s reach beyond its earlier US launch and...
NasdaqGS:COLL
NasdaqGS:COLLPharmaceuticals

What Collegium Pharmaceutical (COLL)'s Revenue Surge and Low Valuation Means For Shareholders

Collegium Pharmaceutical recently reported strong past revenue growth of 31.40%, supported by robust demand for its pain management products Xtampza ER and Belbuca and a focus on abuse-deterrent formulations. The company’s solid financial health and relatively low forward P/E of 5.71 have drawn increased analyst attention, highlighting its position within the healthcare sector’s pain management niche. Against this backdrop, we’ll examine how Collegium’s robust revenue expansion shapes its...
NasdaqGM:EXPI
NasdaqGM:EXPIReal Estate

How Investors May Respond To eXp World Holdings (EXPI) Board Oversight Ruling On Sexual Misconduct Claims

In January 2026, the Delaware Court of Chancery denied a motion to dismiss a derivative lawsuit against eXp World Holdings’ directors and senior executives, ruling that their oversight duties extend to investigating and addressing workplace sexual misconduct allegations tied to company-sponsored events. This is widely viewed as a landmark corporate governance case, signaling that boards can face fiduciary duty claims for failing to act on credible sexual misconduct reports within their...
NYSE:HNI
NYSE:HNICommercial Services

How Investors May Respond To HNI (HNI) Rising Institutional Stakes And New Government Contract Wins

In recent months, HNI Corporation announced it will release its fourth-quarter and full-year 2025 results and host an investor conference call on February 25, 2026, while also securing over US$1.30 million in government furniture contracts across the past year. Fresh SEC filings show large institutions including FIFTH THIRD BANCORP, Vanguard Group Inc, and FMR LLC have meaningfully expanded their HNI holdings, signaling reinforced professional interest in the company’s prospects. Against...
NYSE:BCC
NYSE:BCCTrade Distributors

Should Boise Cascade’s Engineered Wood Expansion Amid Cooling Housing Require Action From BCC Investors?

Boise Cascade recently reported quarterly results that came in modestly ahead of Wall Street expectations, citing steady repair-and-remodel demand and disciplined wood products pricing amid a cooling housing backdrop. Management highlighted ongoing investments in engineered wood capacity and distribution, signaling a focus on strengthening the business even as housing momentum slows. Next, we’ll explore how Boise Cascade’s emphasis on engineered wood capacity expansion influences its broader...